跳至主要内容
临床试验/NCT02815813
NCT02815813已完成不适用

Peer Support and Mobile Technology Targeting Cardiometabolic Risk Reduction in Young Adults With Serious Mental Illness

Dartmouth-Hitchcock Medical Center4 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2017年7月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
4
主要终点
Weight

研究概览

简要总结

This is a four year project evaluating the effectiveness of a group-based lifestyle intervention (PeerFIT) supported by mobile health (mHealth) technology and social media compared to Basic Education in fitness and nutrition supported by a wearable Activity Tracking device (BEAT) in achieving clinically significant improvements in weight loss and cardiorespiratory fitness in young adults with serious mental illness (SMI).

详细描述

The objective of this study is to evaluate the effectiveness of a group-based lifestyle intervention (PeerFIT) supported by mobile health (mHealth) technology and social media to promote weight loss and improved fitness in young adults with serious mental illness (SMI). The study is a two-arm randomized controlled trial conducted in real world mental health settings to evaluate the effectiveness of the 12-month PeerFIT intervention compared to Basic Education in fitness and nutrition supported by a wearable Activity Tracking device (BEAT) in achieving clinically significant improvements in weight loss and cardiorespiratory fitness. The investigators will enroll 144 overweight and obese (BMI ≥ 25) young adults ages 18 to 35 with SMI attending one of two community mental health who are interested in losing weight and improving fitness. The investigators hypothesize that PeerFIT compared to BEAT will be associated with a greater proportion of participants who achieve cardiovascular risk reduction at 6 and 12 months follow-up as indicated by either clinically significant weight loss (5% or greater) or increased fitness (>50 m on the six-minute walk test). The investigators also hypothesize that PeerFIT compared to BEAT will be associated with greater improvements in A1c and lipid profiles at 6 and 12 months follow-up. They will also investigate two theoretical mechanisms of action hypothesized to account for greater weight loss and increased cardiorespiratory fitness among participants assigned to PeerFIT: 1) improved self-efficacy and 2) increased peer support for health behavior change. The investigators hypothesize that the relationship between PeerFIT and weight loss and improved fitness will be mediated by improved self-efficacy and peer support for health behavior change.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Young adults ages 18 to 35
  • Chart diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depression
  • Overweight or obese defined as BMI ≥25
  • Enrolled in treatment at the agency for at least 3 months prior to study recruitment
  • Have not started taking Clozapine or Olanzapine antipsychotic medications over the prior 2 months (dose changes are allowed)
  • Able and willing to give written informed consent to participate in the study or able to assent with guardian consent
  • Willingness to be randomized to either of the two conditions
  • Able and willing to attend the weekly 60-minute weight management session, participate in the weekly 1-hour physical activity sessions, and use the Facebook and mHealth (i.e., Fitbits and text messaging) components of the PeerFIT program

排除标准

  • Medical contraindication to weight loss (e.g., cancer, stroke, liver failure)
  • Medical conditions (e.g., diabetes, angina) that do not receive medical clearance by a primary care provider
  • Major surgery planned or likely to occur within the next 6 months
  • Prior or planned bariatric surgery
  • Use of prescription weight loss medication within the past 6 months
  • 5% or greater weight loss in 3 months prior to baseline
  • Currently enrolled in another weight reduction program
  • Pregnant or planning a pregnancy, or breastfeeding during study period
  • Cognitive impairment sufficient to interfere with participant's ability to provide informed consent, complete study questionnaires, or participate in a group intervention as indicated by a Mini Mental Status Examination score <24
  • Active substance use determined to be incompatible with participation in the intervention identified by screening questionnaire that assesses for excessive use according to intake limits by gender
  • Use of anabolic steroids with the drug taken at least "most days of the week for the previous month"
  • Planning to leave agency or move out of geographic area within 12 months
  • People who are non-English speakers or who have major visual or hearing impairment will be excluded given the need to read the program materials and interact with technology.

结局指标

主要结局

Weight

时间窗: Baseline, 6 months, and 12 months

Participants' weight will be measured in pounds (lbs.) on a flat, even surface with the use of a high-quality, calibrated professional medical scale, with the participant wearing indoor clothing and no shoes.

6-minute Walk Test

时间窗: Baseline, 6 months, and 12 months

After a baseline blood pressure has been obtained, participants are asked to walk a measured distance as far as they are able in 6 minutes.

次要结局

  • Hemoglobin A1C(Baseline, 6 months, and 12 months)
  • Self-efficacy for Exercise Behaviors Assessed Using the Self-efficacy for Exercise Behaviors (SEB) Scale(Six months and 12 months)
  • Social Provisions Scale (SPS)(Six months and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kelly Aschbrenner, PhD

Senior Scientist

Dartmouth-Hitchcock Medical Center

研究点 (4)

Loading locations...

相似试验